Loading...

NITO N2OFF INC Company Mergers 8-K Filing

N2FF

NT

N2OFF INC

(NITO)

2025 8-K

Amended Acquisition Filing

MitoCareX Acquisition

Compliance Regained

Stockholder Approval

Stock Split Announcement

N2OFF Loan Agreement

Loan Agreement Update

Funding Agreement Update

Asset Acquisitions

Merger of Equals

Debt Restructuring

Equity Offerings

Securities Agreement

Share Purchase Agreement

Acquisition Agreement

Nasdaq Compliance

Patent Opposition Win

Nasdaq Compliance

Equity Issuance

Securities Agreement Correc...

Funding and Acquisition

Debt Settlement

Annual Meeting Results

Financing Agreement

Capacity Increase

Solar Project Approval

Loan Agreement and Loan and...

Special Meeting

Promissory Note Sale

Distribution of Holdings

Special Meeting

Entry into a Material Agree...

Appointment of Director

Merger Agreement

Promissory Note Issued

Compliance regained with mi...

Reverse Stock Split

Acquisition of Plantify Shares

Stock Exchange Agreement

Stock Exchange Agreement

Equity Purchase Agreement

Delisting Notice

Merger of Equals

Securities Exchange Agreement

Appointment of Interim CFO

Departure of Directors or C...

External Links:

On October 20, 2025, N2OFF, Inc. completed its acquisition of MitoCareX Bio Ltd., paying $700,000 in cash and issuing 1,171,942 shares of its common stock. This acquisition aims to enhance its drug discovery capabilities for treating resistant cancers.

AI Assistant

N2OFF INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.